Health & Biotech
Health & Biotech
SomnoMed taps tech for new board hires, posts full-year profit
Health & Biotech
MGC Pharma seals Russia joint venture for its medical products
Health & Biotech
Dimerix is tapping a potential multi-billion dollar FSGS market opportunity
Health & Biotech
Osteopore attracts $8.5m from top-tier instos to expand its bone healing tech horizons
Health & Biotech
Health Kick Podcast: Chemo’s diminishing role, the ‘personalised’ approach to cancer treatment and PTX’s CAR-T innovations
Health & Biotech
For medtech company Micro-X, COVID-19 highlighted the importance of being prepared
Health & Biotech
HealthEngine to pay $2.9m for selling user data, changing reviews
Health & Biotech
Kazia Therapeutics continues strong month with more good news from US health regulators
Health & Biotech
MGC Pharma’s medical spray has success in COVID-19 clinical trial
Health & Biotech
Weed Week: Pot proves its worth in a pandemic as Aussie use rates climb
Health & Biotech
Check up: A good fortnight to be a small cap health investor
Health & Biotech
APA in deal to sell Respiri’s wheezo to members
Health & Biotech
Oui oui! MVP buys back Penthrox rights in Europe
Health & Biotech
Victoria’s coronavirus curve tipped to flatten by September: report
Health & Biotech
Aged care operator Estia falls to loss as COVID-19 costs bite
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.